Welcome to the Stanford Department of Neurosurgery
Comprised of 60 neurosurgeons and research faculty, and performing over 4000 neurosurgical operations covering the full spectrum of neurological conditions every year, we are consistently ranked among the best centers in the nation for neurosurgery. We are fortunate to have excellent facilities and the most technologically advanced equipment in the world to help us treat neurological diseases for both adult and pediatric patients. In addition, our hospitals offer the only Level 1 Trauma Center between San Francisco and San Jose, and our Stroke Center was the first in the nation to be certified as a comprehensive Stroke Center by The Joint Commission. These certifications recognize our hospitals as having state-of-the-art equipment, infrastructure, staffing and training to diagnose and treat patients with the most severe and complex cases. Together, we are driving forward the most innovative technologies in neurosurgery – from cutting-edge neuroscience research and clinical trials to the widespread clinical implementation of our discoveries.
Stanford Neurosurgery News
Brain surgeon: 'If you're Black and a woman, nothing else is visible'
Stanford neurosurgeon Dr. Odette Harris shares first-hand accounts of how race and racism can impact a doctor’s and a patient’s experience, with the Today Show.
U.S. Olympic And Paralympic Committees Launch VR Concussion Education Series ‘CrashCourse’
Stanford's TeachAids has collaborated with the Stanford Neurosurgical Simulation and Virtual Reality Center to offer a new concussion education series for young athletes.
Telemedicine During COVID-19 and a Changing Health Care System
Stanford neurosurgeon Dr. John Ratliff discusses healthcare challenges during the COVID-19 pandemic and shelter-in-place orders, and how telemedicine is helping caregivers continue to take care of their patients.
Connecting Patients with Loved Ones During COVID-19
Neurosurgery resident, Adela Wu, MD, reflects on the new reality of caring for brain surgery patients during the COVID-19 outbreak when visitors are kept away from loved ones in the hospital.
Gel Smooths Cells’ Ride Through Syringes in Regenerative Therapy
A new study by Stanford neurosurgical researcher Giles Plant, PhD, reports that a customized gel developed at Stanford acts as a shock absorber for regenerative cells during and after their perilous journey through the tip of a syringe to the targeted tissue.